Ticker
ADVMCompany Name
ADVERUM BIOTECHNOLOGIES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
---|---|---|---|
6/30/2025 | -0.69% | $ 51.83M | $ 359K |
3/31/2025 | -0.29% | $ 43.03M | $ 123K |
12/31/2024 | -177.84% | $ 67.48M | $ 120M |
9/30/2024 | -76.51% | $ 156.85M | $ 120.01M |
6/30/2024 | -88.9% | $ 135M | $ 120.01M |
3/31/2024 | -60.34% | $ 199.47M | $ 120.37M |
12/31/2023 | -0.13% | $ 367.36M | $ 489K |
9/30/2023 | -0.53% | $ 91.93M | $ 489K |
6/30/2023 | -0.26% | $ 184.82M | $ 488K |
3/31/2023 | -0.71% | $ 84.48M | $ 604K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for ADVERUM BIOTECHNOLOGIES INC is calculated as follows: (-1 * CF - Equity [ $ 384.54M ]) / Market Cap [ $ 1.19B ]
(=) Buyback Yield [ -32.39% ]
Minimum
Dec 31, 2024
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.28K |
---|---|
min | -8.43% |
max | 8.43% |
average | 0.64% |
median | 0.01% |
std | 2.71% |